|
Volumn 53, Issue 4, 2012, Pages 2170-2180
|
AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOPOIETIN 1;
ANGIOPOIETIN 2;
HYBRID PROTEIN;
TREBANANIB;
ANIMAL;
ARTICLE;
AUTORADIOGRAPHY;
C57BL MOUSE;
CAPILLARY PERMEABILITY;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG EFFECT;
EYE;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
IN SITU HYBRIDIZATION;
MACACA FASCICULARIS;
MALE;
METABOLISM;
MOUSE;
NEWBORN;
PATHOLOGY;
RETINA BLOOD VESSEL;
RETINA NEOVASCULARIZATION;
RETROLENTAL FIBROPLASIA;
SUBRETINAL NEOVASCULARIZATION;
TISSUE DISTRIBUTION;
ANGIOGENESIS INHIBITORS;
ANGIOPOIETIN-1;
ANGIOPOIETIN-2;
ANIMALS;
ANIMALS, NEWBORN;
AUTORADIOGRAPHY;
CAPILLARY PERMEABILITY;
CHOROIDAL NEOVASCULARIZATION;
DISEASE MODELS, ANIMAL;
EYE;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
IN SITU HYBRIDIZATION;
INFANT, NEWBORN;
MACACA FASCICULARIS;
MALE;
MICE;
MICE, INBRED C57BL;
RECOMBINANT FUSION PROTEINS;
RETINAL NEOVASCULARIZATION;
RETINAL VESSELS;
RETINOPATHY OF PREMATURITY;
TISSUE DISTRIBUTION;
|
EID: 84862634400
PISSN: None
EISSN: 15525783
Source Type: Journal
DOI: 10.1167/iovs.11-7381 Document Type: Article |
Times cited : (30)
|
References (0)
|